Quick Answer
Anixa Biosciences Inc reported Total Assets of $16.08 million for the year ending 2025.
- Anixa Biosciences Inc showed a decrease of -25.5% in Total Assets from 2024 to 2025.
- This data is from Anixa Biosciences Inc's annual report (Form 10-K), filed with the SEC on January 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $8.03 million | Q2 2012: $6.79 million | Q3 2012: $5.89 million | Q1 2014: $10.33 million | Q2 2014: $10.50 million | Q3 2014: $13.40 million | Q1 2015: $13.27 million | Q2 2015: $11.13 million | Q3 2015: $10.28 million | Q4 2015: $9.34 million | Q1 2016: $8.65 million | Q2 2016: $7.21 million | Q3 2016: $6.32 million | Q1 2017: $4.22 million | Q2 2017: $7.25 million | Q3 2017: $8.41 million | Q1 2018: $7.49 million | Q2 2018: $7.36 million | Q3 2018: $7.29 million | Q1 2019: $6.47 million | Q2 2019: $7.77 million | Q3 2019: $6.84 million | Q1 2020: $9.45 million | Q2 2020: $5.92 million | Q3 2020: $9.36 million | Q1 2021: $14.60 million | Q2 2021: $38.50 million | Q3 2021: $37.06 million | Q1 2022: $35.24 million | Q2 2022: $32.80 million | Q3 2022: $32.56 million | Q1 2023: $28.31 million | Q2 2023: $27.60 million | Q3 2023: $26.58 million | Q1 2024: $25.37 million | Q2 2024: $24.36 million | Q3 2024: $22.91 million | Q1 2025: $18.91 million | Q2 2025: $16.98 million | Q3 2025: $17.65 million | Q4 2025: $16.08 million | Q1 2026: $15.23 million.
- Over the full 16 years of available data (2010 to 2025), Anixa Biosciences Inc's Total Assets has grown by 60.1%.
- Historical annual values: Fiscal year 2025: $16.08 million | Fiscal year 2024: $21.59 million | Fiscal year 2023: $25.52 million | Fiscal year 2022: $30.41 million | Fiscal year 2021: $36.26 million | Fiscal year 2020: $9.45 million | Fiscal year 2019: $6.29 million | Fiscal year 2018: $6.45 million | Fiscal year 2017: $8.81 million | Fiscal year 2016: $5.63 million | Fiscal year 2015: $9.34 million | Fiscal year 2014: $9.06 million | Fiscal year 2013: $5.44 million | Fiscal year 2012: $5.66 million | Fiscal year 2011: $8.65 million | Fiscal year 2010: $10.05 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: